|Bid||2.45 x 500|
|Ask||3.10 x 500|
|Day's Range||2.45 - 2.66|
|52 Week Range||0.49 - 3.68|
|PE Ratio (TTM)||-4.06|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Galectin Therapeutics, Inc. (GALT) was a big mover last session, as the company saw its shares rise nearly 7% on the day amid huge volumes.
Illumina Inc. (ILMN), a leading provider of tools and integrated systems for analysis of genetic variation and function, is scheduled to report first-quarter 2017 financial results on Apr 25, after the closing bell.
Here is a look at five companies including Pfizer (PFE) that sport a favorable Zacks Rank and have a positive earnings ESP.
We expect Integra LifeSciences Holdings Corporation (IART) to beat expectations when it reports its first-quarter 2017 results, after market close on Apr 26.
GNC Holdings, Inc. (GNC) -- a specialty retailer of health and nutrition related products -- is scheduled to report first-quarter 2017 financial results on Apr 18, before the opening bell.
On March 28, Galectin Therapeutics Inc (NASDAQ: GALT ) provided an update on the progress of its lead program , the Phase 2b trial of GR-MD-02 in Non-Alcoholic Steato-Hepatitis patients with cirrhosis ...